Zumiez Inc. Announces Fiscal 2017 Fourth Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq futures outperform after Nvidia puts AI fears to rest
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil gains as traders weigh prospects of easing Middle East supply disruptions
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
Zumiez, Inc. (ZUMZ) PT Raised to $27 at Baird Following 4Q Beat
March 19, 2018 8:58 AM EDTBaird raised its price target on Zumiez, Inc. (NASDAQ: ZUMZ) to $27.00 (from $25.00) while maintaining a Neutral rating following the company's 4Q earnings report. ZUMZ reported EPS of $0.80, $0.02 above consensus. Revenue grew +16.9% including benefits from an extra week, favorable currency, and $3.8 million related to a... More
